Transforming growth factor beta 1 induces apoptotic cell death in cultured human gastric carcinoma cells

K Yanagihara1, M Tsumuraya

  • 1Department of Pathology, Hiroshima University, Japan.

Cancer Research
|July 15, 1992
PubMed

Insights

Transforming growth factor beta 1 (TGF-beta 1) inhibits growth and induces irreversible cell death in specific human gastric scirrhous carcinoma cells. This process involves apoptosis, requiring new protein synthesis for its full effect.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Transforming growth factor beta 1 (TGF-beta 1) is a known growth inhibitor for various cell types, including tumor cells.
  • Two human gastric scirrhous carcinoma cell lines, HSC-39 and HSC-43, were previously established and characterized.

Purpose of the Study:

  • To investigate the effect of TGF-beta 1 on the proliferation and viability of HSC-39 and HSC-43 cells.
  • To compare the response of these scirrhous carcinoma cell lines to TGF-beta 1 with five other human gastric adenocarcinoma cell lines.

Main Methods:

  • Treatment of gastric carcinoma cell lines with varying concentrations of TGF-beta 1.
  • Assessment of cell proliferation, viability, DNA fragmentation, and chromatin condensation.
  • Ultrastructural analysis of cell nuclei.
  • Evaluation of cycloheximide's effect on TGF-beta 1-induced cell death and DNA fragmentation.

Main Results:

  • TGF-beta 1 strongly inhibited proliferation and induced irreversible cell death in HSC-39 and HSC-43 cells in a dose-dependent manner (up to 4 ng/ml).
  • Other gastric adenocarcinoma cell lines tested were unresponsive to TGF-beta 1.
  • TGF-beta 1 treatment led to DNA fragmentation and chromatin condensation, indicative of apoptosis.
  • Cell death and DNA fragmentation were partially inhibited by cycloheximide, suggesting a requirement for new protein synthesis.

Conclusions:

  • TGF-beta 1 effectively induces apoptosis and cell death in human gastric scirrhous carcinoma cells (HSC-39 and HSC-43) in vitro.
  • The apoptotic process appears to be mediated by the activation of a specific signal transduction pathway.
  • The differential response to TGF-beta 1 highlights potential therapeutic targets in gastric cancer treatment.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...